Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderately Hypofractionated Radiotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06409910
What this trial is testing

Comparing Moderately Ultra Hypofractionated Radiation Treatments for Prostate Cancer

Who this might be right for
Post-Operative Prostate Cancer
University Health Network, Toronto 204
Not applicableLooking for participantsNCT04610372
What this trial is testing

5500/20 vs. SABR or Brachytherapy for PRimary OligoMetastatic Prostate Cancer Treatment (PROMPT)

Who this might be right for
Oligometastatic Prostate Cancer
British Columbia Cancer Agency 168
Not applicableLooking for participantsNCT05665920
What this trial is testing

Efficacy and Safety of Ultra_HYPofractionated RadiotHerapy in Women With BrEast CaNcer Receiving Regional Nodal Radiation vs Nodal Moderate Hypofractionated Radiotherapy

Who this might be right for
Malignant Breast Neoplasm
Instituto Brasileiro de Controle do Cancer 36
Testing effectiveness (Phase 2)Looking for participantsNCT05038332
What this trial is testing

Post-prostatectomy Radiation Therapy--Moderate Versus Ultra-hypofractionated (Also Known as Stereotactic Body Radiation Therapy [SBRT])

Who this might be right for
Prostate Cancer
University of Michigan Rogel Cancer Center 136
Testing effectiveness (Phase 2)Looking for participantsNCT06389422
What this trial is testing

Phase II Study of Moderate-dose Hypofractionated RT Combined With Pembrolizumab for HCC With Diffuse Tumor Thrombosis

Who this might be right for
Hepatocellular CarcinomaRadiotherapyPembrolizumab+1 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 30
Testing effectiveness (Phase 2)Looking for participantsNCT07507773
What this trial is testing

Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall

Who this might be right for
Soft Tissue Sarcoma AdultSoft Tissue Sarcoma (Excluding GIST)Soft Tissue Sarcoma of the Trunk and Extremities+1 more
Centre Oscar Lambret 135
Not applicableLooking for participantsNCT05313815
What this trial is testing

Moderate Hypofractionated Boost to the Prostate With Pelvic RT in High Risk Prostate Cancer

Who this might be right for
Prostate Cancer
University Health Network, Toronto 100
Not applicableStudy completedNCT02361515
What this trial is testing

Hypofractionated Radiotherapy Versus Stereotactic Irradiation With Hyaluronic Acid

Who this might be right for
Prostatic Adenocarcinoma
Hospices Civils de Lyon 96
Not applicableLooking for participantsNCT05786742
What this trial is testing

Ultra Hypofractionnated Radiotherapy With HDR Brachytherapy Boost.

Who this might be right for
Prostate CancerRadiotherapy Side EffectHypofractionation+3 more
CHU de Quebec-Universite Laval 205
Not applicableActive Not RecruitingNCT05705921
What this trial is testing

Standard Moderately Hypofractionated RT vs. Ultra-hypofractionated Focal Lesion Ablative Microboost in Prostate Cancer

Who this might be right for
Prostate Cancer
The Netherlands Cancer Institute 484